One possibility is that impairment of the OTUD3 function in SCCs, similarly to what was observed in breast carcinoma, may destabilize the tumor suppressor PTEN, thereby activating the AKT-mediated oncogenic signaling [203]. This evidence concerns the gene AKT1 and neoplasm.